Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Oxford Biomedica (OXB) Share Price

Price 602.00p on 23-03-2026 at 19:35:07
Change -15.00p -2.43%
Buy 607.00p
Sell 604.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Sell 21,806.00 at 610.379p
Day's Volume: 346,592
Last Close: 602.00p
Open: 593.00p
ISIN: GB00BDFBVT43
Day's Range 583.00p - 626.00p
52wk Range: 232.50p - 950.00p
Market Capitalisation: £727.65m
VWAP: 606.43729p
Shares in Issue: 120.87m

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Small Cap, FTSE Small Cap ex Investment Trusts

Oxford Biomedica (OXB) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 21,806 610.379p SI Trade
Suspected SELL Trade
 17:03:59 - 23-Mar-26
Buy* 3 602.00p Automatic Execution
 16:38:21 - 23-Mar-26
Buy* 80,558 602.00p Suspected BUY Trade
 16:35:03 - 23-Mar-26
Sell* 111 606.00p SI Trade
 16:27:55 - 23-Mar-26
Sell* 14 606.00p Automatic Execution
 16:27:55 - 23-Mar-26
Sell* 110 606.00p SI Trade
 16:27:38 - 23-Mar-26
Sell* 34 606.00p Automatic Execution
 16:27:38 - 23-Mar-26
Sell* 42 606.00p Automatic Execution
 16:27:38 - 23-Mar-26
Sell* 110 605.00p SI Trade
 16:27:37 - 23-Mar-26
Buy* 261 607.00p Automatic Execution
 16:27:36 - 23-Mar-26
See more Oxford Biomedica trades

Oxford Biomedica (OXB) Share Price History

Time period:
to
Date Open High Low Close Volume
23rd Mar 2026 (Mon) 593.00 626.00 583.00 602.00 346,592
20th Mar 2026 (Fri) 613.00 626.00 601.00 617.00 654,479
19th Mar 2026 (Thu) 630.00 638.00 618.00 618.00 246,841
18th Mar 2026 (Wed) 630.00 661.00 630.00 644.00 538,383
17th Mar 2026 (Tue) 650.00 650.00 625.00 637.00 243,628
16th Mar 2026 (Mon) 642.00 642.00 625.00 633.00 93,494
13th Mar 2026 (Fri) 630.00 638.00 622.00 630.00 104,796
12th Mar 2026 (Thu) 630.00 641.00 625.00 631.00 164,565
11th Mar 2026 (Wed) 672.00 672.00 630.00 637.00 138,514
10th Mar 2026 (Tue) 591.00 651.00 591.00 651.00 202,230
9th Mar 2026 (Mon) 610.00 615.00 592.00 615.00 259,659
6th Mar 2026 (Fri) 669.00 669.00 614.00 624.00 206,795
5th Mar 2026 (Thu) 656.00 659.00 637.00 638.00 127,926
4th Mar 2026 (Wed) 635.00 659.00 617.00 659.00 285,432
3rd Mar 2026 (Tue) 670.00 670.00 616.00 626.00 373,910
2nd Mar 2026 (Mon) 662.00 662.00 630.00 645.00 329,716
27th Feb 2026 (Fri) 631.00 663.00 629.00 663.00 1,067,990
26th Feb 2026 (Thu) 627.00 632.00 599.00 621.00 647,572
25th Feb 2026 (Wed) 680.00 684.00 618.00 632.00 2,068,914
24th Feb 2026 (Tue) 757.00 757.00 667.00 683.00 1,118,844
See more Oxford Biomedica price history

Oxford Biomedica (OXB) Regulatory News

Date Source Headline
18th Mar 2026 7:00 am RNS-R Licensing agreement with VVMF
9th Mar 2026 7:53 am RNS Admission to Trading
4th Mar 2026 11:45 am RNS Admission to Trading Application
3rd Mar 2026 7:00 am RNS Capital Markets Day and investor conferences
2nd Mar 2026 7:00 am RNS Total Voting Rights
27th Feb 2026 1:31 pm RNS Form 8.5 (EPT/RI)-Replacement of Oxford Biomedica
26th Feb 2026 3:20 pm RNS Form 8.3 - Oxford Biomedica plc
26th Feb 2026 1:49 pm RNS Form 8.5 (EPT/RI)-Replacement of Oxford Biomedica
26th Feb 2026 12:33 pm RNS Form 8.3 - Oxford Biomedica plc
26th Feb 2026 11:09 am RNS Form 8.5 (EPT/NON-RI) - Oxford Biomedica plc
See more Oxford Biomedica regulatory news

Oxford Biomedica (OXB) Share News

LONDON BROKER RATINGS: Goldman raises Croda; Jefferies likes Diploma

23rd Mar 2026 09:01

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

LONDON BRIEFING: GSK gains Japan nod; Anglo to delist shares in Zurich

23rd Mar 2026 07:59

(Alliance News) - GSK makes regulatory progress in Japan for a cancer therapy, Anglo American moves to delist from the Swiss exchange as part of its restructuring, and Applied Nutrition reports strong interim growth while holding back on shareholder payouts. Read More

UK earnings, trading statements calendar - next 7 days

19th Mar 2026 14:38

Read More

IN BRIEF: Oxford Biomedica inks new licensing and option deal

18th Mar 2026 12:22

Oxford BioMedica PLC - Oxford, England-based gene and cell therapy developer - Enters a five-year licensing and option agreement with Viral Vector Manufacturing Facility, an Australian contract development and manufacturing organisation (CDMO) and "the country's first commercial manufacturing facility of its kind", having signed a non-binding terms sheet in October. VVMF will have a non-exclusive global licence to use Oxford BioMedica's inAAVate platform "know-how and intellectual property", and an option to extend the licence to the LentiVector platform. OXB says it will receive a low single-digit million licence fee and is eligible for future platform use payments. Expects the contract to enable VVMF "to accelerate its operational and commercial readiness to provide advanced viral vector technologies to customers, capturing global demand with a particular focus on the fast-growing APAC region, and positioning Australia as a regional hub for high‑quality cell and gene therapy manufacturing." Read More

EQT abandons Oxford BioMedica takeover bid after proposals rejected

25th Feb 2026 16:02

(Alliance News) - EQT Fund Management SARL confirmed on Wednesday it has no intention of making an offer for Oxford BioMedica PLC. Read More

See more Oxford Biomedica news
FTSE 100 Latest
Value9,894.15
Change-24.18

Login to your account

Forgot Password?

Not Registered